Future Science OA
Volume 5, 2019 - Issue 3
Open access
1,693
Views
1
CrossRef citations to date
0
Altmetric
Commentary
GALLIUM Trial: The Tortoise (Rituximab) and the Hare (Obinutuzumab) Race
Ricardo García-Muñoz1 Department of Hematology, Hospital San Pedro, Logroño, La Rioja, SpainCorrespondence[email protected]
, Judit Anton-Remirez2 Department of Physical Medicine & Rehabilitation, Complejo Hospitalario de Navarra, Pamplona, Spain
, María Josefa Nájera1 Department of Hematology, Hospital San Pedro, Logroño, La Rioja, Spain
, Elena Gutierrez-Gamarra3 Department of Hematology, Hospital Poniente, Almería, El Ejido, Andalucía, Spain
, Raisa Peralta1 Department of Hematology, Hospital San Pedro, Logroño, La Rioja, Spain
& Jesús Feliu1 Department of Hematology, Hospital San Pedro, Logroño, La Rioja, Spain
Article: FSO375
|
Received 14 Dec 2018, Accepted 18 Jan 2019, Published online: 26 Feb 2019
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.